26
2023
-
04
Haizhi Biotechnology showcased at the 47th Chengdu Beauty Expo.
On April 20, the 47th Chengdu Beauty Expo grandly opened as the first large-scale beauty exhibition in Western China in 2023! Haizhi Bio showcased its products at the expo, reuniting with old friends and meeting new partners.

Haizhi Bio focuses on the repair of skin and mucosal injuries, with a layout in transdermal drug delivery and health care for skin and mucosa. The main business currently involves the research, development, production, and sales of medical devices, cosmetics, and other series of products. The company's main business is based on four main product lines, including medical aesthetics, oral care, nursing, and beauty, providing one-stop OEM/CDMO services for new and old friends.
Haizhi Bio has established a complete range of Class II medical device products for skin and mucosal repair, including a full series of products such as hyaluronic acid, recombinant human collagen, and trehalose. Haizhi Bio is also entering the Class III medical device market and has begun the research and industrialization of functional proteins, becoming an important participant in China's light medical aesthetics market.


About Haizhi Bio: Jiangsu Haizhi Bio Pharmaceutical Co., Ltd., located in the Jiangbei New District (referred to as Haizhi Bio), is a comprehensive high-tech enterprise integrating research and development, production, and sales, focusing on the research and development and industrialization of topical transdermal drug delivery formulations. Haizhi Bio has successively obtained a series of independent research and development achievements, applied for 27 patents, and registered 76 trademarks. Since 2018, it has been recognized as a private technology enterprise in Jiangsu Province, a national/Jiangsu/Nanjing high-tech enterprise, a technology-based small and medium-sized enterprise, and a "specialized, refined, distinctive, and innovative" small and medium-sized enterprise in Nanjing.


More news